XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
COMMON STOCK
ADDITIONAL PAID-IN CAPITAL
RETAINED EARNINGS
ACCUMULATED OTHER COMPREHENSIVE LOSS
TREASURY SHARES
NON-CONTROLLING INTERESTS
Balance, beginning of period at Dec. 31, 2023   $ 561 $ 1,242 $ 22,759 $ (5,295) $ (7,076) $ 179
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (41)        
Issuance of shares under stock compensation plans and employee stock purchase plans     88     284  
Net income attributable to the Company $ 3,316     3,272     44
Dividend equivalents declared       (10)      
Dividends declared       (1,501)      
Other comprehensive income (loss), net of tax 305       305    
Purchase of treasury shares (900)         (900)  
Distributions and other changes             (29)
Balance, end of period at Sep. 30, 2024 $ 13,882   1,289 24,520 (4,990) (7,692) 194
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 3.05            
Balance, beginning of period at Jun. 30, 2024   561 1,197 24,578 (5,527) (7,442) 198
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     84        
Issuance of shares under stock compensation plans and employee stock purchase plans     8     50  
Net income attributable to the Company $ 752     747     5
Dividend equivalents declared       (3)      
Dividends declared       (802)      
Other comprehensive income (loss), net of tax 537       537    
Purchase of treasury shares           (300)  
Distributions and other changes             (9)
Balance, end of period at Sep. 30, 2024 $ 13,882   1,289 24,520 (4,990) (7,692) 194
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 1.63            
Balance, beginning of period at Dec. 31, 2024 $ 13,535 561 1,370 25,306 (6,240) (7,655) 193
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (48)        
Issuance of shares under stock compensation plans and employee stock purchase plans     135     285  
Net income attributable to the Company 3,400     3,339     61
Dividend equivalents declared       (12)      
Dividends declared       (1,685)      
Other comprehensive income (loss), net of tax 799       799    
Purchase of treasury shares (1,000)         (1,002)  
Distributions and other changes             (48)
Balance, end of period at Sep. 30, 2025 $ 15,359   1,457 26,948 (5,441) (8,372) 206
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 3.43            
Balance, beginning of period at Jun. 30, 2025   $ 561 1,362 27,088 (5,244) (8,000) 209
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     83        
Issuance of shares under stock compensation plans and employee stock purchase plans     12     30  
Net income attributable to the Company $ 757     747     10
Dividend equivalents declared       (4)      
Dividends declared       (883)      
Other comprehensive income (loss), net of tax (197)       (197)    
Purchase of treasury shares           (402)  
Distributions and other changes             (13)
Balance, end of period at Sep. 30, 2025 $ 15,359   $ 1,457 $ 26,948 $ (5,441) $ (8,372) $ 206
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividends declared per share (in dollars per share) $ 1.80